Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
HEALTHCARE LEADS EUROPE LOWER
A fall in healthcare stocks is leading major European stock indexes lower on Friday, with vaccine markers hit particularly hard after Trump nominated RFK Jr. to lead the top U.S. health body.
Kennedy has been criticized for making false medical claims, including that vaccines are linked to autism.
European-listed vaccine makers - GSK GSK.L, Sanofi SASY.PA and Biontech 22UAy.DE among others - are lower by between 3.3%-9%.
Overall, the healthcare subsector .SXDP is underperforming, down 2.2%, compared to a 0.7% drop for the broader STOXX 600 .STOXX.
The index is on track to end a choppy week down by about 0.5%.
Switzerland's SMI .SSMI, which has a heavy weighting towards healthcare stocks, is the worst performing major bourse in Europe, falling about 1%.
In other corporate news, Evotec EVTG.DE shares are surging almost 18% after the company received a takeover approach from Halozyme Therapeutics HALO.O.
Here's your opening snapshot:
(Samuel Indyk)
*****
FRIDAY'S OTHER LIVE MARKETS POSTS:
EUROPEAN STOCK FUTURES HEAD SOUTH CLICK HERE
CHINESE CONSUMERS SPEND MORE, JUST NOT ON PROPERTY CLICK HERE
China's mixed October data keeps stimulus calls alive https://reut.rs/3YPXD6v
European shares mostly lower https://reut.rs/3AJ3t1h
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.